Skip to main content
Clinical Trials/CTRI/2020/09/027732
CTRI/2020/09/027732
Completed
未知

An observational study to explore the involvement of inflammation and depression on the occurrence of chemotherapy-related cognitive impairment in lymphoma patients

Jamia Hamdard0 sites83 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C858- Other specified types of non-Hodgkin lymphoma
Sponsor
Jamia Hamdard
Enrollment
83
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient must have histologically and cytologically confirmed lymphoma; patient receiving chemotherapy for the treatment of lymphoma; capable of giving informed consent; willing to participate in the study.

Exclusion Criteria

  • Patient below 18 years of age, history of cognitive impairment and Alzheimerââ?¬•s disease; history of depression; history of head injury; patient with history of any type of cancer; any cancer patient with brain involvement; ongoing psychotropic medications; history of schizophrenia or any other neuropsychiatric disorders; habit of any substance of abuse; using any concurrent medication for any neuropsychiatric disorder; using anti\-inflammatory drugs; incompetent for interview; not willing to participate and give consent for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials